Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01114048
What this trial is testing

Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 78
Large-scale testing (Phase 3)Ended earlyNCT03440411
What this trial is testing

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 9
Testing effectiveness (Phase 2)Study completedNCT00743288
What this trial is testing

Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncotherapeutics 40
Very early researchNot Yet RecruitingNCT07458659
What this trial is testing

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Chulalongkorn University 3
Early research (Phase 1)Study completedNCT01344707
What this trial is testing

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Who this might be right for
Advanced Hematologic Malignancies
4SC AG 36
Not applicableUnknownNCT01042717
What this trial is testing

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Who this might be right for
Multiple MyelomaNon-Hodgkins Lymphoma
Shi, Patricia, M.D. 10
Not applicableNo Longer AvailableNCT03850704
What this trial is testing

Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Masonic Cancer Center, University of Minnesota
Not applicableEnded earlyNCT01081028
What this trial is testing

Connect® MM- The Multiple Myeloma Disease Registry

Who this might be right for
Multiple Myeloma
Celgene 3,011
Not applicableEnded earlyNCT04545333
What this trial is testing

The clonoSEQ® Watch Registry

Who this might be right for
Acute Lymphoblastic Leukemia, Adult B-CellChronic Lymphocytic LeukemiaMultiple Myeloma+1 more
Adaptive Biotechnologies 465
Early research (Phase 1)Active Not RecruitingNCT04960579
What this trial is testing

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Poseida Therapeutics, Inc. 275
Not applicableWithdrawnNCT02298816
What this trial is testing

B-Cell Hematologic Malignancy Vaccination Registry

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia+4 more
Wake Forest University Health Sciences
Not applicableLooking for participantsNCT04114084
What this trial is testing

Sleep Apnea in Patients With MGUS and MM

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Michael Tomasson 200
Large-scale testing (Phase 3)Study completedNCT00179647
What this trial is testing

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene Corporation 1,913
Early research (Phase 1)Looking for participantsNCT07139509
What this trial is testing

Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma(MM)
Xi'an No.3 Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04564703
What this trial is testing

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 160
Large-scale testing (Phase 3)Active Not RecruitingNCT03539744
What this trial is testing

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
AbbVie 265
Not applicableLooking for participantsNCT06028087
What this trial is testing

Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment

Who this might be right for
Multiple MyelomaDiagnosis
Gruppo Italiano Malattie EMatologiche dell'Adulto 736
Testing effectiveness (Phase 2)Study completedNCT04083534
What this trial is testing

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Regeneron Pharmaceuticals 43
Testing effectiveness (Phase 2)WithdrawnNCT02756663
What this trial is testing

Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT00872352
What this trial is testing

Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

Who this might be right for
Multiple MyelomaPeripheral Neuropathy
Wolfson Medical Center 30
Next Page